Weight loss is not enough to treat dyslipidemia in women

Published Date: 06 Mar 2023

Obesity continues to exist around the world despite the risk to health and death from illness and disease.

Read Full News

Latest News

AI-Assisted MRI: Could Muscle Fat Signal CV Risk?

Researchers say AI based body composition analysis may improve early cardiometabolic risk detection, although routine MRI screening remains premature.

Drug Options for Three High-Risk Prediabetes Types

Identifying three high-risk prediabetes types can help physicians decide when to add metformin, GLP-1/GIP agents, or SGLT2 inhibitors to lifestyle care.

Increased Mortality After Radiotherapy for Pituitary Adenoma

Patients with pituitary adenomas who receive radiotherapy with or without surgery have a higher rate of long-term mortality than the general population, largely due to cerebrovascular disease.

What Can Patients With HFpEF Gain From Iron Supplementation?

Intravenous iron supplementation may resolve iron deficiency in patients with heart failure with preserved ejection fraction but may not improve exercise haemodynamics or heart function.

EU Supports Anti-Inflammatory for Secondary Heart Risk

The European Medicine Agency has recommended marketing authorization for a hybrid colchicine medicine for secondary prevention of atherothrombotic events in adults with stable coronary disease.

EMA Backs Options for Broadening Obesity Care in Europe

EMA has recommended Ablymico and Liraglutide STADA and an oral formulation of Wegovy, potentially expanding GLP-1 treatment options for diabetes and weight management across Europe.

Todays Updates

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Todays Updates

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Latest News

Researchers say AI based body composition analysis may improve early cardiometabolic risk detection, although routine MRI screening remains premature.

Identifying three high-risk prediabetes types can help physicians decide when to add metformin, GLP-1/GIP agents, or SGLT2 inhibitors to lifestyle care.

Patients with pituitary adenomas who receive radiotherapy with or without surgery have a higher rate of long-term mortality than the general population, largely due to cerebrovascular disease.

Intravenous iron supplementation may resolve iron deficiency in patients with heart failure with preserved ejection fraction but may not improve exercise haemodynamics or heart function.

The European Medicine Agency has recommended marketing authorization for a hybrid colchicine medicine for secondary prevention of atherothrombotic events in adults with stable coronary disease.

EMA has recommended Ablymico and Liraglutide STADA and an oral formulation of Wegovy, potentially expanding GLP-1 treatment options for diabetes and weight management across Europe.

News All Time

Eating for One: The Future of Personalized Nutrition

Nutrition science is closing in on truly personalized dietary advice. The bigger challenge? Making sure it does not only land on wealthy plates.

When the Defibrillator Stays in Its Box

After teenage footballer Adam Ankers died in cardiac arrest while a defibrillator sat unused on the pitch, 13 organisations now have until June to respond to a coroner's report.

Is Hypertension Undertreated in Pediatrics?

Long-term implications may be underestimated, and new data show relatively low medication use.

Prior Auth Rules Vary Widely Across Insurers, Study Finds

A new study finds that prior authorization requirements vary widely across major insurers and suggests large language models could help streamline how authorization rules are interpreted and processed.

Retatrutide Delivers Unprecedented Weight Loss in Phase 3

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

Experts Debate Weight-Loss Controversies

Microdosing, drugs vs surgery, hormone replacement therapy to induce weight loss, and confusing nomenclature for loss of muscle function were among the hot topics at Obesity Medicine 2026.

Dual Cholesterol Measures May Improve Heart Risk Prediction

Non-high-density lipoprotein cholesterol and apolipoprotein B levels are linked to the risk for atherosclerotic cardiovascular disease, and assessing both markers may improve risk prediction.

Women Show Longer Door-to-Needle Time for Stroke Than Men

Women with acute ischaemic stroke experience a longer door-to-needle time in the emergency department, despite both having similar access to treatments.

Atrial-Fixation TMVR Appears Feasible, Durable at 1 Year

Early feasibility study results are promising for AltaValve, which is designed with a novel atrial fixation system to minimize complications linked to subvalvular fixation.

The Bare Minimum You Need to Do to Add a Year to Your Life

Very small changes across sleeping, eating, and exercise can lead to dramatic gains in lifespan and healthspan.

Why Some Centenarians Maintain Younger Immune Systems

Researchers find that preserved immune signaling and key immune cells may help explain why some centenarians avoid severe diseases longer than expected.

Human Coaching Boosts Adherence in AI Wearable Obesity Study

The results suggest that hybrid models may outperform fully automated approaches.

Is Rapid Weight Loss More Effective Than Gradual Loss?

Rapid weight loss delivered in a structured program yields better outcomes than gradual weight loss, but other factors also need to be considered.

How Lifeline Brought the AMR Crisis to the London Stage

Real doctors joined the London cast of Lifeline the Musical to bring the growing threat of antimicrobial resistance to wider audiences.

Cardiorenal Benefits of GLP-1s Found in Type 1 Diabetes

A large database study shows lower risk for major adverse cardiovascular events and end-stage kidney disease, with no increase in adverse events.

Low Natriuretic Peptide Levels in Obesity? HF Risk Persists

Adults with obesity may have natriuretic peptide levels below the usual rule-out threshold and still have increased odds of signs and symptoms of heart failure and other risks.

Recommended News For You

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma

Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds

Can MRI Curb Chemo Overtreatment in Breast Cancer?

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

Recommended Articles For You

From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine  

Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications 

New Research on Craniopharyngioma  

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

2.

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

3.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

4.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

5.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

1.

Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management

2.

Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology

3.

Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers

4.

Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data

5.

Precision Oncology: Tailoring Cancer Treatment for the Individual

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

5.

Navigating the Complexities of Ph Negative ALL - Part XI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot